WALTHAM, MA -- (MARKET WIRE) -- February 06, 2007 -- EyeGate Pharma, a privately-held, specialty pharmaceutical company pioneering the use of iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications, today announced that Stephen From, President and Chief Executive Officer, will present at the 9th Annual BIO CEO & Investor Conference which will be held at The Waldorf-Astoria Hotel in New York City from February 12-14, 2007. Mr. From will present a corporate overview on February 14th at 11:15 AM in the Conrad Suite and he will be available for one-on-one meetings during the conference. For more information about the 9th Annual BIO CEO & Investor Conference please visit http://ceo.bio.org/opencms/ceo/2007.
